Page last updated: 2024-10-25

dapi and Lymphoma, Large B-Cell, Diffuse

dapi has been researched along with Lymphoma, Large B-Cell, Diffuse in 2 studies

DAPI: RN given refers to parent cpd.

Lymphoma, Large B-Cell, Diffuse: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.

Research Excerpts

ExcerptRelevanceReference
"Herbimycin A is a general protein tyrosine kinase inhibitor active as an antiproliferative compound against different types of mammalian cells."1.31Model of inhibition of the NPM-ALK kinase activity by herbimycin A. ( Arnold, MD; Frist, AY; Pulford, K; Turturro, F, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, MJ1
Kwon, HY1
Lee, EO1
Lee, HJ1
Ahn, KS2
Kim, MO1
Kim, CH1
Kim, SH1
Turturro, F1
Arnold, MD1
Frist, AY1
Pulford, K1

Other Studies

2 other studies available for dapi and Lymphoma, Large B-Cell, Diffuse

ArticleYear
DMNQ-S17 inhibits constitutive NF-kappaB activation leading to induction of apoptosis through the activation of caspase-3 in human myeloid leukemia U937 cells.
    Life sciences, 2008, Sep-26, Volume: 83, Issue:13-14

    Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspase Inhibitors; Cytochromes c; Drug Screening Assay

2008
Model of inhibition of the NPM-ALK kinase activity by herbimycin A.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:1

    Topics: Anaplastic Lymphoma Kinase; Apoptosis; Benzoquinones; Blotting, Western; Cell Cycle; Enzyme Inhibito

2002